BSEBoard Meeting2d ago · 10 Nov 2026, 10:32 pm
Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Update on board meeting for addition in agenda item for Allotment of Preferential Equity Shares and Convertible Warrants.
Natural Capsules Ltd · 524654
✦ AI SummaryFundraise
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the update on board meeting for the addition of preferential equity shares and convertible warrants.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natural Capsules Ltd - 524654 - Update on board meeting
Attachments (1)
📄pdf
Download →
e600638f-8262-4080-9641-e3e0b3458207.pdf
View document text
A C C R E D I T E D
ISO/IEC 17021
CERTIFICATION BODY
Date: November 10, 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, PJ Towers Exchange Plaza, C-1, Block G
Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai – 400001 Mumbai – 400051
Scrip Code: 524654 Symbol: NATCAPSUQ
Sub: In addition to intimation for Board Meeting dated November 06, 2026 – Addition to Agenda regarding
Board Meeting scheduled on Friday November 13, 2026,
Dear Sir / Madam,
Further to our intimation dated November 06, 2026 informing the Exchange(s) about the Board Meeting Scheduled to
be held on Friday November 13, 2026, inter alia, to consider and approve the Unaudited Consolidated & Standalone
Financial Results for the Quarter and Half Yearly ended September 30, 2026, we wish to further inform that the Board
of Directors will, at the said meeting, also consider the following additional item of business:
1. Allotment of 1,12,500 Equity Shares and 4,50,000 Fully Convertible Equity Warrants on a Preferential
Basis to Mr. Sunil Laxminarayan Mundra (Promoter Individual) pursuant to Chapter V of the SEBI (Issue of
Capital and Disclosure Requirements) Regulations, 2018, as amended, and in accordance with the approval
granted by the members of the Company at the Extra-Ordinary General Meeting held on September 09, 2026
and receipt of in-principle approvals from BSE Limited and National Stock Exchange of India Limited
on November 04, 2026.
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for
prevention of Insider Trading and Code of Corporate Disclosure Practices, We wish to inform you that the “Trading
Window” for dealing in the Equity Shares of the Company has remained closed for all Designated Person and their
Immediate Relatives w.e.f. October 01, 2026 till the conclusion of 48 hours after the declaration of Financial Results of
the Company for the Quarter and Half Yearly ended September 30, 2026.
Yours Faithfully,
For Natural Capsules Limited
Akshay Dutta
Company Secretary and Compliance Officer
M.No. A80481